<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7315836\results\search\zoonosis\results.xml">
  <result pre="Î²-CoVs, the severe acute respiratory syndrome coronavirus (SARS-CoV), and the" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) have caused severe epidemics in the past.4,5"/>
  <result pre="confirms that TMPRSS2 expressing VeroE6 cells are highly susceptible to" exact="SARS-CoV-2 infection," post="highlighting the importance of TMPRSS2 in the replication cycle.19"/>
  <result pre="observed in hemagglutinin (HA) proteins of highly virulent avian and" exact="human influenza" post="viruses, and similar furin-like processing events are also observed"/>
  <result pre="events are also observed for other RNA viruses such as" exact="Ebola" post="virus and Marburg virus, human immune deficiency virus (HIV),"/>
  <result pre="received 40 mg/kg of mAb 201 or mAb 68 before" exact="SARS-CoV infection" post="showed complete protection from reinfection of lung tissues.43,44 Cross-reactivity"/>
  <result pre="Table 2) could target ACE2, and showed antiviral activity against" exact="SARS-CoV infection" post="in vitro, with an EC50 value of 41.6 Î¼M,"/>
  <result pre="was shown to block the entry of SARS, MERS, and" exact="Ebola" post="virus by specifically inhibiting the cathepsin L activity.111 More"/>
  <result pre="(EC50 value of 273 nM) showed some inhibition activity for" exact="Ebola" post="virus infection (EC50 value of 193 nM) of human"/>
  <result pre="a new promising point for the treatment of SARS and" exact="Ebola" post="virus infections.114 Recently, in a cell-based assay screen of"/>
  <result pre="Simon Cocklin and is currently working in infectious disease-related (HIV-1," exact="Ebola" post="virus, SARS-CoV-2) computationally aided drug design supported by biochemical,"/>
  <result pre="His interests have since expanded to include inhibitor discovery against" exact="Ebola" post="and SARS-CoV-2 viruses. His research spans multiple disciplines, including"/>
  <result pre="ADAM A disintegrin and metalloproteinase bnAbs broadly neutralizing antibodies COVID-19" exact="coronavirus disease 2019" post="CPE cytopathic effect ELISA enzyme-linked immunosorbent assay FP fusion"/>
  <result pre="hepatic C virus IFA immunofluorescence assay KM immunized Kunming MERS-CoV" exact="Middle East respiratory syndrome" post="coronavirus MHV mouse hepatitis coronavirus NTD N-terminal domain PD"/>
  <result pre="181, 271â€&quot;280. 10.1016/j.cell.2020.02.052.32142651 MilletJ. K.; WhittakerG. R.Host cell entry of" exact="Middle East respiratory syndrome" post="coronavirus after two-step, furin-mediated activation of the spike protein."/>
  <result pre="M.; HaagmansB. L.; GrosveldF.; BoschB. J.A human monoclonal antibody blocking" exact="SARS-CoV-2 infection." post="Nat. Commun.2020, 11, 225110.1038/s41467-020-16256-y.32366817 BrouwerP. J. M.; CanielsT. G.;"/>
  <result pre="RNA synthesis reveals potent inhibition of diverse coronaviruses including the" exact="Middle East respiratory syndrome" post="virus. PLoS Pathog.2014, 10, e100416610.1371/journal.ppat.1004166.24874215 TurnerA. J.Angiotensin-converting enzyme 2:"/>
  <result pre="DuL.; YuF.; MaC.; YeS.; YuenK. Y.; ZhangR.; JiangS.Structure-based discovery of" exact="Middle East respiratory syndrome" post="coronavirus fusion inhibitor. Nat. Commun.2014, 5, 306710.1038/ncomms4067.24473083 ChannappanavarR.; LuL.;"/>
  <result pre="W.; QinC.; SunF.; ShiZ. L.; ZhuY.; JiangS. B.; LuL.Inhibition of" exact="SARS-CoV-2 infection" post="(previously 2019-nCoV) by a highly potent pan-coronavirus fusion inhibitor"/>
  <result pre="SunY.; ZhangH.; ShiJ.; ZhangZ.; GongR.Identification of a novel inhibitor against" exact="Middle East respiratory syndrome" post="coronavirus. Viruses2017, 9, 25510.3390/v9090255. XiaS.; XuW.; WangQ.; WangC.; HuaC.;"/>
  <result pre="WangZ.; YangB.; LiQ.; WenL.; ZhangR.Clinical features of 69 cases with" exact="coronavirus disease 2019" post="in Wuhan, China. Clin. Infect. Dis.2020, ciaa27210.1093/cid/ciaa272.32176772 BoschB. J.;"/>
  <result pre="L in the late endosome/lysosome and block the entry of" exact="Ebola" post="virus, Middle East respiratory syndrome coronavirus (MERS-CoV), and severe"/>
  <result pre="the late endosome/lysosome and block the entry of Ebola virus," exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus (SARS-CoV)."/>
  <result pre="BasuA.; AbrahamP.; GangakhedkarR. R.; BhargavaB.Perspectives for repurposing drugs for the" exact="coronavirus disease 2019." post="Indian J. Med. Res.2020, 151, 160â€&quot;171. 10.4103/ijmr.IJMR_585_20.32317408 BlanchardE.; BelouzardS.;"/>
  <result pre="6, e2892310.1371/journal.pone.0028923.22205980 LiuQ.; XiaS.; SunZ.; WangQ.; DuL.; LuL.; JiangS.Testing of" exact="Middle East respiratory syndrome" post="coronavirus replication inhibitors for the ability to block viral"/>
  <result pre="are potent inhibitors of severe acute respiratory syndrome coronavirus and" exact="Middle East respiratory syndrome" post="coronavirus fusion. J. Virol.2016, 90, 8924â€&quot;8933. 10.1128/JVI.01429-16.27466418 DyallJ.; ColemanC."/>
  <result pre="and laboratory effects of convalescent plasma therapy for patients with" exact="Middle East respiratory syndrome" post="coronavirus infection: a study protocol. SpringerPlus2015, 4, 70910.1186/s40064-015-1490-9.26618098"/>
 </snippets>
</snippetsTree>
